Sign in
Explore the registryTrack Risvutatug rezetecan's trials

A Study of Risvutatug Rezetecan in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC)

Risvutatug rezetecan (Ris-Rez)OngoingNot yet recruitingPhase 3Open NCT07802704 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…